Tsai Wan-Jung A, McCormick Kathleen M, Brazeau Daniel A, Brazeau Gayle A
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, 517 Hochstetter Hall, North Campus, University at Buffalo, Amherst, New York 14260, USA.
Exp Biol Med (Maywood). 2007 Nov;232(10):1314-25. doi: 10.3181/0704-RM-92.
Previous work showed that estrogen replacement attenuates muscle growth in immature rats. The present study examined muscle insulin-like growth factor-1 (IGF-1) and myostatin expression to determine whether these growth regulators might be involved in mediating estrogen's effects on muscle growth. IGF-1 and myostatin message and protein expression in selected skeletal muscles from 7-week-old sham-ovariectomized (SHAM) and ovariectomized rats that received continuous estrogen (OVX/E2) or solvent vehicle (OVX/CO) from an implant for 1 week or 5 weeks was measured. In the 1-week study, ovariectomy increased IGF-1 mRNA expression in fast extensor digitorum longus and gastrocnemius muscles; the increase was reversed by estrogen replacement. A similar trend was observed in the slow soleus muscle, although the change was not statistically significant. In contrast to mRNA, muscle IGF-1 protein expression was not different between SHAM and OVX/ CO animals in the 1-week study. One week of estrogen replacement significantly decreased IGF-1 protein level in all muscles examined. Myostatin mRNA expression was not different among the 1-week treatment groups. One week of estrogen replacement significantly increased myostatin protein in the slow soleus muscle but not the fast extensor digitorum longus and gastrocnemius muscles. There was no treatment effect on IGF-1 and myostatin expression in the 5-week study; this finding suggested a transient estrogen effect or upregulation of a compensatory mechanism to counteract the estrogen effect observed at the earlier time point. This investigation is the first to explore ovariectomy and estrogen effects on skeletal muscle IGF-1 and myostatin expression. Results suggest that reduced levels of muscle IGF-1 protein may mediate estrogen's effect on growth in immature, ovariectomized rats. Increased levels of muscle myostatin protein may also have a role in mediating estrogen's effects on growth in slow but not fast skeletal muscle.
先前的研究表明,雌激素替代疗法会抑制未成熟大鼠的肌肉生长。本研究检测了肌肉中胰岛素样生长因子-1(IGF-1)和肌肉生长抑制素的表达,以确定这些生长调节因子是否参与介导雌激素对肌肉生长的影响。测量了7周龄假去卵巢(SHAM)大鼠以及去卵巢后接受持续雌激素(OVX/E2)或溶剂载体(OVX/CO)植入1周或5周的大鼠特定骨骼肌中IGF-1和肌肉生长抑制素的信息核糖核酸(mRNA)及蛋白表达。在为期1周的研究中,去卵巢增加了快肌趾长伸肌和腓肠肌中IGF-1 mRNA的表达;雌激素替代可逆转这种增加。在慢肌比目鱼肌中也观察到了类似趋势,尽管变化无统计学意义。与mRNA不同,在为期1周的研究中,SHAM组和OVX/CO组动物的肌肉IGF-1蛋白表达没有差异。1周的雌激素替代显著降低了所有检测肌肉中的IGF-1蛋白水平。在为期1周的治疗组中,肌肉生长抑制素mRNA表达没有差异。1周的雌激素替代显著增加了慢肌比目鱼肌中的肌肉生长抑制素蛋白,但在快肌趾长伸肌和腓肠肌中未增加。在为期5周的研究中,对IGF-1和肌肉生长抑制素的表达没有治疗效果;这一发现表明雌激素的作用是短暂的,或者存在一种补偿机制上调以抵消早期观察到的雌激素效应。本研究首次探讨了去卵巢和雌激素对骨骼肌IGF-1和肌肉生长抑制素表达的影响。结果表明,肌肉IGF-1蛋白水平降低可能介导雌激素对未成熟去卵巢大鼠生长的影响。肌肉生长抑制素蛋白水平升高也可能在介导雌激素对慢肌而非快肌生长的影响中发挥作用。